Press releases | WebDisclosure

PRESS RELEASE

published on 01/15/2025 at 07:30, 1 year ago

PERSPECTIVES ET DEVELOPPEMENTS
ODYSSEA 2024 et lancement du plan 2028 : Fountaine Pajot renforce son positionnement avec une stratégie ambitieuse de développement, d'innovation et de durabilité

Durabilité Nautisme FOUNTAINE PAJOT Odyssea 2024 Plan 2028
PRESS RELEASE

published on 01/15/2025 at 07:30, 1 year ago

Informations privilégiées / Autres communiqués
Hospitex remporte un important appel d'offres pour l'Hôpital Universitaire Gaetano Martino à Messine, Italie. Contrat de 668 K€ sur 3 ans pour fournir de l'alcool médical et hospitalier

Italie Accreditation Hospitex Appel D'offres Alcool Médical
PRESS RELEASE

published on 01/15/2025 at 07:30, 1 year ago

Informations privilégiées / Autres communiqués
GenSight Biologics annonce les résultats cliniques à 5 ans de la thérapie génique LUMEVOQ chez les patients atteints de NOHL, démontrant une amélioration bilatérale de l'acuité visuelle et un profil de sécurité favorable

Thérapie Génique GenSight Biologics NOHL LUMEVOQ Résultats Cliniques
PRESS RELEASE

published on 01/15/2025 at 07:30, 1 year ago

Inside Information / Other news releases
GenSight Biologics announces the publication of 5-year outcomes for patients treated with LUMEVOQ® gene therapy, showing sustained bilateral improvement in visual acuity and favorable safety profile

Gene Therapy GenSight Biologics LUMEVOQ Visual Acuity Safety Profile
PRESS RELEASE

published on 01/15/2025 at 07:00, 1 year ago

Swiss Re proposes new members for election to the Board of Directors
Swiss Re proposes Morten Hübbe and George Quinn as new Board members for election. Philip Ryan and Sir Paul Tucker will not seek re-election. AGM on 11 April 2025

Board Of Directors Insurance AGM Swiss Re Election
PRESS RELEASE

published on 01/15/2025 at 06:30, 1 year ago

Formycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara®
Formycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi®, a biosimilar to Stelara®, for various inflammatory diseases. Global biosimilar approval news

Biosimilar Formycon Fresenius Kabi FYB202 MHRA Approval
PRESS RELEASE

published on 01/15/2025 at 06:01, 1 year ago

Original-Research: dynaCERT Inc. (von GBC AG): Management Interview
GBC AG conducted in-depth research on dynaCERT Inc., focusing on growth strategies and sustainable innovation for diesel engines. The company's HydraGEN™ technology reduces diesel consumption and CO2 emissions, offering significant fuel savings potential

CO2 Emissions GBC AG Diesel Engines DynaCERT Inc. HydraGEN™ Technology
PRESS RELEASE

published on 01/15/2025 at 06:00, 1 year ago

Sales fourth quarter and financial year 2024 Ad hoc announcement pursuant to Art. 53 LR
Bossard Holding AG announces sales results for the fourth quarter and financial year 2024. Read more on www.bossard.com

Financial Year 2024 Ad Hoc Announcement Fourth Quarter Sales Results Bossard Holding AG
PRESS RELEASE

published on 01/15/2025 at 04:40, 1 year ago

Global Financial Leaders Meet in Hong Kong to Explore Growth Engines
The 18th Asian Financial Forum in Hong Kong gathers global leaders to discuss finance, investment opportunities, and market developments, with a focus on Middle East markets and bilateral co-operation

Investment Opportunities Asian Financial Forum Hong Kong Finance Middle East Markets
PRESS RELEASE

published on 01/15/2025 at 03:10, 1 year ago

Ficus Technology Holdings Limited (8107.HK) Distributes Products from China Co-op 832 Platform Expand Product Offering, Enhance Margin, and Support Local Agricultural Products
Ficus Technology Holdings Limited announces strategic partnership with China Co-op E-Commerce Co., Limited to distribute 832 Products through Ficus Discovery platform, enhancing market reach and product offerings

Supply Chain Management China Co-op 832 Products Ficus Technology Holdings Limited Ficus Discovery

Published on 01/28/2026 at 05:35, 3 hours 16 minutes ago

Banyan Gold Intersects High-Grades and Visible Gold at AurMac, Yukon, Canada
Published on 01/28/2026 at 02:00, 6 hours 51 minutes ago

Troy Minerals Announces Debt Settlement
Published on 01/28/2026 at 01:00, 7 hours 51 minutes ago

Boron One Announces Increase to Private Placement
Published on 01/27/2026 at 22:15, 10 hours 36 minutes ago

Biomind Labs Announces CAD $2.52 Million Private Placement Financing
Published on 01/27/2026 at 20:20, 12 hours 31 minutes ago

FutureGen Industries is Unaware of Any Material Change

View all ACCESSWIRE

Published on 01/28/2026 at 08:30, 21 minutes ago

Empiric Student Property Plc - Suspension
Published on 01/28/2026 at 08:01, 50 minutes ago

Extension of Share Repurchase Programme
Published on 01/28/2026 at 08:00, 51 minutes ago

Transaction in Own Shares
Published on 01/28/2026 at 08:00, 51 minutes ago

VALBIOTIS SA: VALBIOTIS annonce l’initiation de couverture de son titre par Euroland Corporate
Published on 01/28/2026 at 08:00, 51 minutes ago

Aquis Stock Exchange: Restoration to trading

View all EQS

Published on 01/28/2026 at 07:30, 1 hour 21 minutes ago

Biophytis enters strategic agreement in Asia and secures $20 million for launch of Phase 3 trial in sarcopenia
Published on 01/28/2026 at 07:30, 1 hour 21 minutes ago

Biophytis conclut un accord stratégique en Asie et sécurise 20 M$ pour le lancement de sa Phase 3 dans la sarcopénie
Published on 01/27/2026 at 19:00, 13 hours 51 minutes ago

MISE A DISPOSITION RAPPORT FINANCIER SEMESTRIEL 2025/2026
Published on 01/27/2026 at 19:00, 13 hours 51 minutes ago

RAPPORT FINANCIER SEMESTRIEL 25/26 TFF GROUP
Published on 01/27/2026 at 19:00, 13 hours 51 minutes ago

RAPPORT FINANCIER SEMESTRIEL 25/26 TFF GROUP

View all LES ECHOS COMFI WIRE

News